Active, not recruitingNot applicableNCT04385732

Melanoma Surveillance Photography (MSP) to Improve Early Detection of Melanoma in Ultra-high and High Risk Patients

Studying Neuroendocrine neoplasm

Last synced from ClinicalTrials.gov May 13, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Melanoma and Skin Cancer Trials Limited
Principal Investigator: Victoria Mar
Monash University and Alfred Health
Intervention: 2D or 3D Melanoma Surveillance Photography(device)
Enrollment: 670 target
Eligibility: 18 years · All sexes
Timeline: 2021 – 2025

Study locations (12)

Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
Newcastle Skin Check, Newcastle, New South Wales, Australia
Dermatology Clinical Trials Unit, Westmead Hospital, Sydney, New South Wales, Australia
Melanoma Institute Australia, Wollstonecraft, New South Wales, Australia
Diamantina Institute, University of Queensland, Brisbane, Queensland, Australia
FNQH Cairns Skin Cancer Centre, Cairns, Queensland, Australia
Skin Repair Skin Cancer Clinic, Townsville, Townsville, Queensland, Australia
Bendigo Cancer Centre Research Unit, Bendigo Health, Bendigo, Victoria, Australia
Skin Health Institute, Carlton, Victoria, Australia
Phillip Island Health Hub, Bass Coast Health, Cowes, Victoria, Australia
Victorian Melanoma Service, Alfred Health, Melbourne, Victoria, Australia
Wonthaggi Hospital, Bass Coast Health, Wonthaggi, Victoria, Australia

Collaborators

Monash University · University of Sydney · The University of Queensland

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04385732 on ClinicalTrials.gov

Other trials for Neuroendocrine neoplasm

Additional recruiting or active studies for the same condition.

See all trials for Neuroendocrine neoplasm →

← Back to all trials